GlaxoSmithKline Pharma Share Price
GLAXO
₹---₹-- (--%) Past Year
₹--₹--
LH
What’s in news?
Company overview
About
Market cap
| Open₹-- | Close₹-- |
Circuit range₹-- - ₹-- | Day range₹-- - ₹-- | Year range₹-- - ₹-- |
Volume-- | Avg. traded₹-- | Revenue (12m)₹NaN undefined |
GlaxoSmithKline PharmaGlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicines. Its general medicines business has a portfolio of medicines in anti-infectives, pain, dermatology and vitamins. Its general medicines brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact and Physiogel. Its T-bact brand products are used in specific types of bacterial skin infections. The Company's vaccine brands include Shingrix, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicines business is focused on developing medicines for respiratory diseases and human immunodeficiency virus. The Company is also building its presence in other therapeutic areas, such as immunology and oncology. Its specialty medicines brands include Nucala and Trelegy Ellipta.
Read more
GlaxoSmithKline Pharma Key indicators
52 week high₹-- | 52 week low₹-- | P/E ratio |
P/B ratio | ROE-- | ROCE-- |
Dividend yield-- | Debt/Equity ratio | EPS |
Learn more
Featured in
Fundamentals
Financial ratios
Operating profit margin-- | Net profit margin-- |
ROE-- | ROA-- |
ROCE-- |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
GlaxoSmithKline Pharma Share Price history
Day | Open | Close | Day’s change |
---|
Events
No data available at the moment
More
Similar stocks
People also bought
Investment calculators
Upcoming IPOs
No data available at the moment